Hopital Lyon Sud

Pierre-Bénite, Auvergne-Rhône 69310

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Endometrial Cancer, Fallopian Tube Cancer, Low-grade Serous Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Cancer, Recurrent Endometrial Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Cancer, Recurrent Primary Peritoneal Cancer

Studies at this site

• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers — Recruiting now
• A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab — Recruiting now
• A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers — Running, not enrolling